7
May
2024

Metrochem API Privated Limited

Exhibitor at CPHI North America 2024 stand 1313
About Us

Metrochem’s unique value proposition lies in ability to deliver end to end support for a dynamic, ever increasing product portfolio. Our in-house market research and analytics team meticulously selects APIs that provide a unique and competitive market proposition to our customers. Our IP and development teams ensure the tangibility of this advantage. We have so far filed more than 43 patents and assist our customers in NCE and early generic filings. Our expert regulatory team, backed by 500+ successful DMF submission across the g...

  • IN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Intermediates Manufacturer
Other
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Contact info
  • The Watermark, 3rd floor & 4th floor, Plot No 11, Survey No. 9, Whitefields, Kondapur, Hitech City, 500084, Hyderabad, India
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1313

Products Featured at CPHI North America 2024

Metrochem API Private Limited Resources (1)

  • Brochure Metrochem API Private Limited API Brochure Q1 Fy22-23

    Metrochem API Pvt ltd is one of the few vertically integrated Indian Pharmaceutical manufacturer approved by USFDA (EIR), WHO-GMP, COEFPRIS, KFDA & ISO 9001:2008 certification. We hold  few process patents .Our products include API`s, Pellets and intermediates,CRAMS and P2P  in wide variety of segments, mainly Anti Ulcerants, Anti allergic, Anti coagulants, Anti diabetic & Anti Hypertensive’s. Metrochem API Vizag`s manufacturing unit is a green field manufacturing facility in 50,000 sqmts with 700kl reaction volume. We have capability to take a kilo to multi ton batches in the new facility. This USFDA and EUGMP approvable facility started operations in May-2015